Archives
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
Resazurin Cell Viability Assay Kit Workflow
2026-09-20
Build a sensitive, non-destructive cell viability assay around resazurin reduction, with practical guidance for screening, dose-response studies, and mechanistic oncology workflows. Learn how to pair fluorescent readouts with controls and orthogonal apoptosis measurements for more defensible results.
-
S1P/S1PR3 Drives Neuronal Apoptosis After ICH
2026-09-19
The reference study identifies an S1P/S1PR3–TNF-α–caspase-3 axis that contributes to neuronal apoptosis after acute intracerebral hemorrhage. By combining a mouse ICH model with HT22-cell experiments and pharmacological S1PR3 inhibition, it links receptor activity to inflammatory and apoptotic signaling while positioning S1PR3 as a potential neuroprotective target.
-
Ibotenic Acid: NMDA Receptor Agonist Workflows
2026-09-18
Build time-resolved excitotoxicity and circuit-mapping studies with Ibotenic acid, an NMDA receptor agonist that links behavioral, biochemical, immediate-early gene, and histological readouts. This workflow emphasizes formulation control, dose–time separation, and assay selection for reproducible neuroscience research and neurodegenerative disease models.
-
Direct Mouse Genotyping Kit Plus for SCA3 Models
2026-09-18
The Direct Mouse Genotyping Kit Plus simplifies tissue-to-PCR workflows for transgene detection, knockout confirmation, and colony decisions without DNA purification. Its high-fidelity PCR master mix with dye reagents also supports clean gel-based interpretation when researchers are validating complex mouse disease models such as SCA3/MJD.
-
Direct Mouse Genotyping Kit Plus for SCA3
2026-09-17
The Direct Mouse Genotyping Kit Plus strengthens genotype-to-phenotype workflows in SCA3 mouse research. This article connects direct PCR genotyping with the reference study’s neuroinflammation and autophagy findings while defining practical controls and limitations.
-
Rifampin Workflows for Transcription Research
2026-09-17
Rifampin is a mechanism-defined rifamycin antibiotic for dissecting bacterial transcription, resistance, and synthetic biology circuits. This practical guide covers stock preparation, exposure design, controls, data interpretation, and troubleshooting for reproducible bench workflows.
-
HotStart™ Universal 2X Green qPCR Master Mix
2026-09-16
A scenario-based guide to using HotStart™ Universal 2X Green qPCR Master Mix (SKU K1170) for gene expression follow-up in cell viability, proliferation, and cytotoxicity studies. It addresses assay variability, inhibitor control, melt curve analysis, data normalization, and practical vendor selection.
-
MK-0812 and the Gut–Liver Axis in MASH Research
2026-09-16
A translational framework for using MK-0812 to test whether CCR2-dependent monocyte trafficking connects intestinal dysfunction with hepatic inflammation in MASH models.
-
10 mM dNTP Mixture for PCR and LNP Workflows
2026-09-15
The 10 mM dNTP mixture provides an equimolar, pH 7.0 source of dATP, dCTP, dGTP, and dTTP for reproducible PCR, qPCR, sequencing, and DNA-template preparation. Its practical value extends to nucleic acid delivery studies, where consistent DNA synthesis helps isolate how LNP surface charge and target-cell state influence functional delivery.
-
Thymoquinone Protects Against Doxorubicin Cardiotoxicity
2026-09-15
A 2025 study found that thymoquinone reduced doxorubicin-associated cardiac injury in mice, with protection linked to Nrf2/HO-1 activation, improved antioxidant status, and attenuation of ferroptosis-related damage. Its integrated cardiovascular, biochemical, immunohistochemical, and ultrastructural design provides a useful framework for studying cardiotoxicity mitigation while emphasizing that anticancer efficacy must be evaluated separately.
-
AMG 9810: TRPV1 Antagonist Workflow Guide
2026-09-14
Build cleaner calcium-imaging and CGRP assays with AMG 9810, a selective competitive TRPV1 antagonist that supports stimulus-specific pain mechanism research. This guide connects practical sensory-neuron workflows with metabolic-stress controls inspired by recent AMPK–SQSTM1 findings.
-
FPS-ZM1 and the RAGE/POMC Bridge
2026-09-14
A translational perspective on how FPS-ZM1 can test RAGE-dependent amyloid beta signaling, neuroinflammation, and hypothalamic RAGE/POMC biology while keeping preclinical evidence distinct from therapeutic claims.
-
NF 449 for Reliable Platelet Assays
2026-09-13
NF 449 (SKU B6716) is a potent purinergic receptor antagonist for experimentally separating P2X1-mediated platelet signaling from broader ATP and ADP responses. This scenario-based guide explains assay selection, concentration interpretation, handling, controls, and practical vendor evaluation using published quantitative evidence.
-
Oltipraz Workflows for Nrf2 and MASLD Research
2026-09-12
Oltipraz provides a defined small-molecule approach for linking Nrf2-dependent phase II enzyme induction with autophagy, ferroptosis, and liver-injury assays. This article translates recent MASLD findings into practical dose-finding, readout-selection, troubleshooting, and mechanistic validation workflows.
-
Cisplatin (CDDP) Workflows for Chemoresistance
2026-09-11
Use Cisplatin (CDDP) as a controlled DNA-damage challenge to connect cell killing with apoptosis, oxidative stress, and chemoresistance mechanisms. This workflow translates the ZNF263–STAT3 findings in colorectal cancer into practical assay designs for viability testing, resistance profiling, and tumor growth inhibition in xenograft models.